Cross-talk between insulin and angiotensin signaling

F. Folli, L. A. Velloso, Mja Saad, C. R. Kahn

Research output: Contribution to journalArticle

Abstract

Angiotensin II (All), acting via its G-protein linked receptor, is an important regulator of cardiac, vascular, and renal function. Following injection of physiologic concentrations of All in rats, there is rapid 3- to 4-fold stimulation of tyrosyl phosphorylation of the major insulin receptor substrates IRS-I and IRS-2, followed by association of these substrates with the p85 subunit of PI 3-kinase in the heart. Phosphorylation of IRS-1 and 2 appears to involve cytoplasmic JAK2 tyrosine kinase which complexes with IRS-l/lRS-2 after All, as well as insulin, stimulation. As in other tissues, insulin stimulation results in a 8- to 30-fold increase in IRS-l and lRS-2associated PI-3 kinase activity. Surprisingly, however. All treatment results in a dose dependent inhibition of basal PI 3-kinase activity and inhibits insulin-stimulated IRS-I and IRS-2-associated PI 3-kinase activity by 75-80%. This ability of All to inhibit PI 3kinase activity occurs without any effect on insulin stimulation of receptor or 1RS tyrosyl phosphorylation, and with no reduction in the binding of p85 to 1RS or the binding of the pi 10 catalytic subunit of PI 3-K to the p85 regulatory subunit. Infusion of a pcptide blocker of the ATI receptor completely prevents All stimulation of IRS-l phosphorylation and the inhibitory effect of All on insulin-stimulated PI 3-kinase activity. Thus, All, acting through the ATI receptor, stimulates 1RS-1/2 tyrosine phosphorylation, but inhibits PI 3-kinase activity. This novel intracellular interaction between G-protein coupled and tyrosine kinase receptors may play an important role in the insulin resistance of hypertension and the association of these conditions with cardiovascular diseases.

Original languageEnglish (US)
JournalJournal of Investigative Medicine
Volume44
Issue number3
StatePublished - 1996
Externally publishedYes

Fingerprint

Angiotensins
Phosphorylation
Phosphatidylinositol 3-Kinases
Insulin
Insulin Receptor
GTP-Binding Proteins
Association reactions
Receptor Protein-Tyrosine Kinases
Substrates
Angiotensin II
Protein-Tyrosine Kinases
Blood Vessels
Insulin Resistance
Rats
Catalytic Domain
Cardiovascular Diseases
Tissue
Hypertension
Kidney
Injections

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Folli, F., Velloso, L. A., Saad, M., & Kahn, C. R. (1996). Cross-talk between insulin and angiotensin signaling. Journal of Investigative Medicine, 44(3).

Cross-talk between insulin and angiotensin signaling. / Folli, F.; Velloso, L. A.; Saad, Mja; Kahn, C. R.

In: Journal of Investigative Medicine, Vol. 44, No. 3, 1996.

Research output: Contribution to journalArticle

Folli, F, Velloso, LA, Saad, M & Kahn, CR 1996, 'Cross-talk between insulin and angiotensin signaling', Journal of Investigative Medicine, vol. 44, no. 3.
Folli, F. ; Velloso, L. A. ; Saad, Mja ; Kahn, C. R. / Cross-talk between insulin and angiotensin signaling. In: Journal of Investigative Medicine. 1996 ; Vol. 44, No. 3.
@article{a8b0d6fbc992489d9250ceed0571bd7a,
title = "Cross-talk between insulin and angiotensin signaling",
abstract = "Angiotensin II (All), acting via its G-protein linked receptor, is an important regulator of cardiac, vascular, and renal function. Following injection of physiologic concentrations of All in rats, there is rapid 3- to 4-fold stimulation of tyrosyl phosphorylation of the major insulin receptor substrates IRS-I and IRS-2, followed by association of these substrates with the p85 subunit of PI 3-kinase in the heart. Phosphorylation of IRS-1 and 2 appears to involve cytoplasmic JAK2 tyrosine kinase which complexes with IRS-l/lRS-2 after All, as well as insulin, stimulation. As in other tissues, insulin stimulation results in a 8- to 30-fold increase in IRS-l and lRS-2associated PI-3 kinase activity. Surprisingly, however. All treatment results in a dose dependent inhibition of basal PI 3-kinase activity and inhibits insulin-stimulated IRS-I and IRS-2-associated PI 3-kinase activity by 75-80{\%}. This ability of All to inhibit PI 3kinase activity occurs without any effect on insulin stimulation of receptor or 1RS tyrosyl phosphorylation, and with no reduction in the binding of p85 to 1RS or the binding of the pi 10 catalytic subunit of PI 3-K to the p85 regulatory subunit. Infusion of a pcptide blocker of the ATI receptor completely prevents All stimulation of IRS-l phosphorylation and the inhibitory effect of All on insulin-stimulated PI 3-kinase activity. Thus, All, acting through the ATI receptor, stimulates 1RS-1/2 tyrosine phosphorylation, but inhibits PI 3-kinase activity. This novel intracellular interaction between G-protein coupled and tyrosine kinase receptors may play an important role in the insulin resistance of hypertension and the association of these conditions with cardiovascular diseases.",
author = "F. Folli and Velloso, {L. A.} and Mja Saad and Kahn, {C. R.}",
year = "1996",
language = "English (US)",
volume = "44",
journal = "Journal of Investigative Medicine",
issn = "1081-5589",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Cross-talk between insulin and angiotensin signaling

AU - Folli, F.

AU - Velloso, L. A.

AU - Saad, Mja

AU - Kahn, C. R.

PY - 1996

Y1 - 1996

N2 - Angiotensin II (All), acting via its G-protein linked receptor, is an important regulator of cardiac, vascular, and renal function. Following injection of physiologic concentrations of All in rats, there is rapid 3- to 4-fold stimulation of tyrosyl phosphorylation of the major insulin receptor substrates IRS-I and IRS-2, followed by association of these substrates with the p85 subunit of PI 3-kinase in the heart. Phosphorylation of IRS-1 and 2 appears to involve cytoplasmic JAK2 tyrosine kinase which complexes with IRS-l/lRS-2 after All, as well as insulin, stimulation. As in other tissues, insulin stimulation results in a 8- to 30-fold increase in IRS-l and lRS-2associated PI-3 kinase activity. Surprisingly, however. All treatment results in a dose dependent inhibition of basal PI 3-kinase activity and inhibits insulin-stimulated IRS-I and IRS-2-associated PI 3-kinase activity by 75-80%. This ability of All to inhibit PI 3kinase activity occurs without any effect on insulin stimulation of receptor or 1RS tyrosyl phosphorylation, and with no reduction in the binding of p85 to 1RS or the binding of the pi 10 catalytic subunit of PI 3-K to the p85 regulatory subunit. Infusion of a pcptide blocker of the ATI receptor completely prevents All stimulation of IRS-l phosphorylation and the inhibitory effect of All on insulin-stimulated PI 3-kinase activity. Thus, All, acting through the ATI receptor, stimulates 1RS-1/2 tyrosine phosphorylation, but inhibits PI 3-kinase activity. This novel intracellular interaction between G-protein coupled and tyrosine kinase receptors may play an important role in the insulin resistance of hypertension and the association of these conditions with cardiovascular diseases.

AB - Angiotensin II (All), acting via its G-protein linked receptor, is an important regulator of cardiac, vascular, and renal function. Following injection of physiologic concentrations of All in rats, there is rapid 3- to 4-fold stimulation of tyrosyl phosphorylation of the major insulin receptor substrates IRS-I and IRS-2, followed by association of these substrates with the p85 subunit of PI 3-kinase in the heart. Phosphorylation of IRS-1 and 2 appears to involve cytoplasmic JAK2 tyrosine kinase which complexes with IRS-l/lRS-2 after All, as well as insulin, stimulation. As in other tissues, insulin stimulation results in a 8- to 30-fold increase in IRS-l and lRS-2associated PI-3 kinase activity. Surprisingly, however. All treatment results in a dose dependent inhibition of basal PI 3-kinase activity and inhibits insulin-stimulated IRS-I and IRS-2-associated PI 3-kinase activity by 75-80%. This ability of All to inhibit PI 3kinase activity occurs without any effect on insulin stimulation of receptor or 1RS tyrosyl phosphorylation, and with no reduction in the binding of p85 to 1RS or the binding of the pi 10 catalytic subunit of PI 3-K to the p85 regulatory subunit. Infusion of a pcptide blocker of the ATI receptor completely prevents All stimulation of IRS-l phosphorylation and the inhibitory effect of All on insulin-stimulated PI 3-kinase activity. Thus, All, acting through the ATI receptor, stimulates 1RS-1/2 tyrosine phosphorylation, but inhibits PI 3-kinase activity. This novel intracellular interaction between G-protein coupled and tyrosine kinase receptors may play an important role in the insulin resistance of hypertension and the association of these conditions with cardiovascular diseases.

UR - http://www.scopus.com/inward/record.url?scp=33749436596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749436596&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749436596

VL - 44

JO - Journal of Investigative Medicine

JF - Journal of Investigative Medicine

SN - 1081-5589

IS - 3

ER -